| Early treatment of COVID-19 with anakinra guided by soluble urokinase plasminogen receptor plasma levels: a double-blind, randomized controlled phase 3 trial E Kyriazopoulou, G Poulakou, H Milionis, S Metallidis, G Adamis, ... Nature medicine 27 (10), 1752-1760, 2021 | 490 | 2021 |
| Post-COVID-19 global health strategies: the need for an interdisciplinary approach Aging clinical and experimental research 32 (8), 1613-1620, 2020 | 344 | 2020 |
| CD4/CD8 ratio normalisation and non-AIDS-related events in individuals with HIV who achieve viral load suppression with antiretroviral therapy: an observational cohort study C Mussini, P Lorenzini, A Cozzi-Lepri, G Lapadula, G Marchetti, E Nicastri, ... The lancet HIV 2 (3), e98-e106, 2015 | 328 | 2015 |
| Usefulness of monitoring HIV drug resistance and adherence in individuals failing highly active antiretroviral therapy: a randomized study (ARGENTA) A Cingolani, A Antinori, MG Rizzo, R Murri, A Ammassari, F Baldini, ... Aids 16 (3), 369-379, 2002 | 311 | 2002 |
| Diagnosis of AIDS-related focal brain lesions: a decision-making analysis based on clinical and neuroradiologic characteristics combined with polymerase chain reaction assays … A Antinori, A Ammassari, A De Luca, A Cingolani, R Murri, G Scoppettuolo, ... Neurology 48 (3), 687-694, 1997 | 292 | 1997 |
| Better response to chemotherapy and prolonged survival in AIDS-related lymphomas responding to highly active antiretroviral therapy A Antinori, A Cingolani, L Alba, A Ammassari, D Serraino, BC Ciancio, ... Aids 15 (12), 1483-1491, 2001 | 278 | 2001 |
| Remdesivir and three other drugs for hospitalised patients with COVID-19: final results of the WHO Solidarity randomised trial and updated meta-analyses H Pan, R Peto, AMH Restrepo, MP Preziosi, V Sathiyamoorthy, QA Karim, ... The Lancet 399 (10339), 1941-1953, 2022 | 276 | 2022 |
| Cytomegalovirus coinfection is associated with an increased risk of severe non–AIDS-defining events in a large cohort of HIV-infected patients M Lichtner, P Cicconi, S Vita, A Cozzi-Lepri, M Galli, S Lo Caputo, ... The Journal of infectious diseases 211 (2), 178-186, 2015 | 231 | 2015 |
| The molecular and phenotypic profile of primary central nervous system lymphoma identifies distinct categories of the disease and is consistent with histogenetic derivation … LM Larocca, D Capello, A Rinelli, S Nori, A Antinori, A Gloghini, ... Blood, The Journal of the American Society of Hematology 92 (3), 1011-1019, 1998 | 219 | 1998 |
| Patient-reported nonadherence to HAART is related to protease inhibitor levels R Murri, A Ammassari, K Gallicano, A De Luca, A Cingolani, D Jacobson, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 24 (2), 123-128, 2000 | 212 | 2000 |
| Clinical epidemiology and survival of progressive multifocal leukoencephalopathy in the era of highly active antiretroviral therapy: data from the Italian Registry … A Antinori, A Cingolani, P Lorenzini, ML Giancola, I Uccella, S Bossolasco, ... Journal of neurovirology 9, 47-53, 2003 | 209 | 2003 |
| Common cardiovascular risk factors and in-hospital mortality in 3,894 patients with COVID-19: survival analysis and machine learning-based findings from the multicentre Italian … A Di Castelnuovo, M Bonaccio, S Costanzo, A Gialluisi, A Antinori, ... Nutrition, Metabolism and Cardiovascular Diseases 30 (11), 1899-1913, 2020 | 205 | 2020 |
| Plasma levels of interleukin-6 and interleukin-10 in preterm neonates evaluated for sepsis C Romagnoli, S Frezza, A Cingolani, A De Luca, M Puopolo, ... European journal of pediatrics 160, 345-350, 2001 | 200 | 2001 |
| Value of combined approach with thallium-201 single-photon emission computed tomography and Epstein-Barr virus DNA polymerase chain reaction in CSF for the diagnosis of AIDS … A Antinori, G De Rossi, A Ammassari, A Cingolani, R Murri, D Di Giuda, ... Journal of clinical oncology 17 (2), 554-554, 1999 | 189 | 1999 |
| Cross-resistance among nonnucleoside reverse transcriptase inhibitors limits recycling efavirenz after nevirapine failure A Antinori, M Zaccarelli, A Cingolani, F Forbici, MG Rizzo, MP Trotta, ... AIDS research and human retroviruses 18 (12), 835-838, 2002 | 185 | 2002 |
| A genotypic drug resistance interpretation algorithm that significantly predicts therapy response in HIV-1-infected patients K Van Laethem, A De Luca, A Antinori, A Cingolani, CF Perno, ... Antiviral therapy 7 (2), 123-129, 2002 | 185 | 2002 |
| Prevalence, associated factors, and prognostic determinants of AIDS-related toxoplasmic encephalitis in the era of advanced highly active antiretroviral therapy A Antinori, D Larussa, A Cingolani, P Lorenzini, S Bossolasco, MG Finazzi, ... Clinical infectious diseases 39 (11), 1681-1691, 2004 | 175 | 2004 |
| Cidofovir in addition to antiretroviral treatment is not effective for AIDS-associated progressive multifocal leukoencephalopathy: a multicohort analysis A De Luca, A Ammassari, P Pezzotti, P Cinque, J Gasnault, J Berenguer, ... Aids 22 (14), 1759-1767, 2008 | 172 | 2008 |
| AIDS-related focal brain lesions in the era of highly active antiretroviral therapy A Ammassari, A Cingolani, P Pezzotti, A De Luca, R Murri, ML Giancola, ... Neurology 55 (8), 1194-1200, 2000 | 159 | 2000 |
| Reduced rate of diagnostic positive detection of JC virus DNA in cerebrospinal fluid in cases of suspected progressive multifocal leukoencephalopathy in the era of potent … A Marzocchetti, S Di Giambenedetto, A Cingolani, A Ammassari, R Cauda, ... Journal of clinical microbiology 43 (8), 4175-4177, 2005 | 154 | 2005 |
